{"version":"1.0","type":"link","title":"Limited Prognostic Impact of Sustained Virologic Response on Atezolizumab plus Bevacizumab Therapy for HCV-Related Unresectable Hepatocellular Carcinoma.","author_name":"Ohama H 외","author_url":"https://prs-insight.online/author/Ohama%20H","provider_name":"PRSinsight","provider_url":"https://prs-insight.online","thumbnail_url":"https://prs-insight.online/og/paper/119910","thumbnail_width":1200,"thumbnail_height":630}